Literature DB >> 12440231

Diabetes among Bedouins in the Negev: the transition from a rare to a highly prevalent condition.

Yunis Abou-Rbiah1, Shimon Weitzman.   

Abstract

BACKGROUND: Previous studies have shown a low prevalence of diabetes and other cardiovascular risk factors among Bedouins living in the Negev desert. New evidence suggests that diabetes is becoming highly prevalent.
OBJECTIVES: To estimate the prevalence of diabetes in the town of Rahat, describe the cardiovascular risk factor profile and therapeutic modalities for diabetes and related conditions in this population, and compare these findings with those in the Jewish population.
METHODS: A complete record review of all known diabetic individuals aged 35 and older registered at the Rahat Clinic (Clalit Health Services) was carried out by a trained nurse and a research assistant. Information on demographic, anthropometric and clinical characteristics was abstracted. Data on prescribed hypoglycemic agents and other medications were also obtained.
RESULTS: Of the 316 known diabetic patients in the clinic, complete data were available for 271 (85.8%). The prevalence of known diabetes was 7.3% in males and 9.9% in females. Females had a significantly higher body mass index than males (30.9 vs. 29, P < 0.002), but lower levels of HBA1c and microalbuminuria. Oral hypoglycemic medications were taken by 69% of women and 76% of men, and insulin by 19% of women and 15% of men.
CONCLUSIONS: Compared with data on Jewish diabetic patients in the Negev and Israel, the overall prevalence of diabetes in the population of Rahat is higher, but their cardiovascular risk profile is better, except for obesity. These findings support the hypothesis that diabetes and obesity have become major public health problems among Bedouins.

Entities:  

Mesh:

Year:  2002        PMID: 12440231

Source DB:  PubMed          Journal:  Isr Med Assoc J            Impact factor:   0.892


  8 in total

1.  Link between retinopathy and nephropathy caused by complications of diabetes mellitus type 2.

Authors:  Pavel Kotlarsky; Arkady Bolotin; Karina Dorfman; Boris Knyazer; Tova Lifshitz; Jaime Levy
Journal:  Int Ophthalmol       Date:  2014-11-13       Impact factor: 2.031

Review 2.  Health and morbidity among Bedouin women in southern Israel: a descriptive literature review of the past two decades.

Authors:  Yulia Treister-Goltzman; Roni Peleg
Journal:  J Community Health       Date:  2014-08

Review 3.  Literature review of type 2 diabetes mellitus among minority Muslim populations in Israel.

Authors:  Yulia Treister-Goltzman; Roni Peleg
Journal:  World J Diabetes       Date:  2015-02-15

4.  Liver Cirrhosis, Etiology and Clinical Characteristics Disparities Among Minority Population.

Authors:  Muhammad Abu Tailakh; Liat Poupko; Najwan Kayyal; Ali Alsana; Asia Estis-Deaton; Ohad Etzion; Alexander Fich; David Yardni; Naim Abu-Freha
Journal:  J Immigr Minor Health       Date:  2021-08-28

5.  The Impact of a Cultural Lifestyle Intervention on Metabolic Parameters After Gestational Diabetes Mellitus A Randomized Controlled Trial.

Authors:  Dana Zilberman-Kravits; Naomi Meyerstein; Yones Abu-Rabia; Arnon Wiznitzer; Ilana Harman-Boehm
Journal:  Matern Child Health J       Date:  2018-06

6.  Self-Reported Type 2 Diabetes and Diabetes-Related Eye Disease in Jews and Arabs in Israel.

Authors:  Inbar Zucker; Hadar Arditi-Babchuk; Teena Enav; Tamar Shohat
Journal:  J Immigr Minor Health       Date:  2016-12

7.  "I Had to Rediscover Our Healthy Food": An Indigenous Perspective on Coping with Type 2 Diabetes Mellitus.

Authors:  Maya Maor; Moflah Ataika; Pesach Shvartzman; Maya Lavie Ajayi
Journal:  Int J Environ Res Public Health       Date:  2021-12-24       Impact factor: 3.390

Review 8.  COVID-19 Vaccination Among the Arab Bedouin Population: Lessons Learned From a Minority Population.

Authors:  Naim Abu-Freha; Hadel Alsana; Sabri El-Saied; Zuya Azbarga; Muhammad Aloka; Tarek Goda; Muhammad Abu Tailakh
Journal:  Int J Public Health       Date:  2022-03-22       Impact factor: 3.380

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.